The global Head and Neck Cancer (HNC) Therapeutics Market is estimated to be valued at USD 2.0 billion in 2025 and is projected to reach USD 6.2 billion by 2035, registering a compound annual growth rate (CAGR) of 12.1% over the forecast period. The Head and Neck Cancer (HNC) Therapeutics Market is experiencing notable advancements …